We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current DTIL market cap is 49.13M. The company's latest EPS is USD -15.0885 and P/E is -0.80.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 10.6M | 8.78M | 19.79M | 13.12M | 7.04M |
| Operating Income | -18.49M | -25.23M | -11.99M | 4.31M | -15.76M |
| Net Income | -28.49M | -25.06M | -11.89M | -8.08M | -16.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 22.24M | 24.29M | 115.53M | 25.1M | 48.73M |
| Operating Income | -87.2M | -109.83M | -39.22M | -102.55M | -48.67M |
| Net Income | -92.88M | -109.01M | -30.6M | -111.64M | -61.32M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 238.17M | 204.5M | 181.7M | 164.34M | 159.78M |
| Total Liabilities | 177.74M | 164.33M | 147.66M | 135.28M | 140.92M |
| Total Equity | 60.43M | 40.18M | 34.04M | 29.06M | 18.86M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 235.23M | 150.16M | 211.5M | 238.17M | 159.78M |
| Total Liabilities | 96.92M | 105.73M | 120.33M | 177.74M | 140.92M |
| Total Equity | 138.31M | 44.43M | 91.17M | 60.43M | 18.86M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -45.75M | -31.46M | -52.6M | -75.69M | -84.11M |
| Investing | -3.32M | -721k | -1.78M | 5.79M | 5.83M |
| Financing | 94.99M | 741k | 2.59M | 2.56M | 5.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -71.02M | -87.39M | -10.85M | -45.75M | -84.11M |
| Investing | -24.67M | -5.03M | -5.8M | -3.32M | 5.83M |
| Financing | 173.37M | 1.33M | 70.52M | 94.99M | 5.39M |
| Market Cap | 49.13M |
| Price to Earnings Ratio | -0.80 |
| Price to Sales Ratio | 1 |
| Price to Cash Ratio | 0.42 |
| Price to Book Ratio | 2.59 |
| Dividend Yield | - |
| Shares Outstanding | 4.06M |
| Average Volume (1 week) | 56.21k |
| Average Volume (1 Month) | 60.54k |
| 52 Week Change | -47.66% |
| 52 Week High | 27.018 |
| 52 Week Low | 8.25 |
| Spread (Intraday) | 1.32 (10.23%) |
| Company Name | Precision BioSciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.precisionbiosciences.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
